Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +11.36%
#3 The Bitcoin Bull The Bitcoin Bull +5.66%
#4 Tornado Cash Tornado Cash +5.29%
#5 BCGame Coin BCGame Coin +5.00%
#6 B3 (Base) B3 (Base) +4.43%
#7 MarsCoin MarsCoin +3.79%
#8 Gas Gas +3.76%
#9 Fake World Assets Fake World Assets +3.61%
#10 The Black Bull The Black Bull +3.12%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
Rangering i aksjer #25718
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Aksjekurs
$1.45
Sist synkronisert: 2026-08-19
Markedsverdi
$46.94M
Endring (1 dag)
0.00%
Endring (1 år)
-18.08%
Land
US
Handel Vicapsys Life Sciences, Inc. (VICP)

Kategori

Healthcare
Aksjeprishistorikk for Vicapsys Life Sciences, Inc. (VICP)
Høyeste sluttskurs: $1.45 den 2026-08-01

Laveste sluttskurs: $4.00K den 1998-02-01
Aksjeprishistorikk for Vicapsys Life Sciences, Inc. fra 1998 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 1.38%
2025 -14.29%
2024 154.87%
2023 174.65%
2022 -50.00%
2021 33.33%
2020 0.00%
2019 -55.29%
2018 -6.80%
2017 -28.00%
2016 3,025.00%
2015 0.00%
2014 22.18%
2013 -67.67%
2012 -34.58%
2011 -94.15%
2010 -77.91%
2009 -6.88%
2008 -58.50%
2007 926.57%
2006 -33.53%
2005 -50.30%
2004 -58.93%
2003 -84.01%
2002 -89.45%
2001 44.98%
2000 27.56%
1999 44.30%
1998 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -16.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US